Antipsychotic switching: results from a one-year prospective, observational study of patients with schizophrenia

By Karagianis Jamie   Williams Richard   Davis Lori   Procyshyn Ric   Monga Neerav   Hanley James   Chandrasena Ranjith   Thakur Aruna   Dickson Ruth  

Current Medical Research and Opinion, Vol. 25, Iss. 9, 2009-09 ,pp. : 2121-2132

Informa Healthcare

Access to resources Recommend Favorite

A prospective, multicentre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in Europe: Broad Effectiveness Trial with Aripiprazole in Europe (EU-BETA)

By Wolf Jürgen   Janssen Firmin   Lublin Henrik   Salokangas Raimo KR   Allain Hervé   Smeraldi Enrico   Bernardo Miguel   Millar Helen   Pans Miranda   Adelbrecht Christine   Laughton Jim   Werner Christian   Maier Wolfgang  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2313-2323

Informa Healthcare

Access to resources Recommend Favorite

Switching from rivaroxaban to warfarin: an open label pharmacodynamic study in healthy subjects

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 6, 2015-06 ,pp. : 907-917

John Wiley & Sons Inc

Access to resources Recommend Favorite

One-Year Outcome and Its Prediction in First-Episode Schizophrenia – A Naturalistic Study

By  

Psychopathology, Vol. 41, Iss. 2, 2007-12 ,pp. : 115-123

Karger

Access to resources Recommend Favorite

Long-term darifenacin treatment for overactive bladder in patients aged 65 years and older: analysis of results from a 2-year, open-label extension study

By Hill Simon   Elhilali Mostafa   Millard Richard J   Dwyer Peter L   Lheritier Karine   Kawakami Fernando T.   Steel Michael  

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2697-2704

Informa Healthcare

Access to resources Recommend Favorite